US Endoscopy announces full market release of the Histolock™ resection device
Mentor, Ohio — April 7, 2015 — US Endoscopy, a world leader in endoscopy device design and manufacturing, is proud to announce the release of the Histolock™ resection device. The Histolock™ device features a stiff monofilament wire and is designed to effectively grab and resect difficult flat lesions during complex polypectomy procedures including endoscopic mucosal resection (EMR).
Existing braided snares on the market tend to slide over the resection site resulting in repeat attempts to capture polyps and lengthened procedure times. The unique design of the Histolock™ device features a stiff twisted wire that lays flat on the mucosa to effectively recruit and resect flat tissue. The mini snare size and torsion spring offers easy maneuverability and controlled placement around lesions while maintaining an open shape after multiple uses.
“The development of the Histolock™ device was driven by our Customer’s need to have a stiff monofilament wire that effectively grips and resects sessile serrated lesions,” says Tony Siracusa, Vice President and General Manager of US Endoscopy. “The Histolock™ device is available in our EMR resection kits that include the essential polypectomy and tissue retrieval devices in one convenient package - offering our Customer’s a complete solution for these challenging cases.”
About US Endoscopy
US Endoscopy, a subsidiary of STERIS Corporation, is a world leader in endoscopy device design and manufacturing, serving the U.S. and international gastrointestinal endoscopy markets. By listening and delivering solutions in the field of endoscopy, our unique lines of devices provide better, more enhanced product options for GI clinicians. A significant and growing portion of sales are from endoscopic devices created by the company's new product development team with the guidance and direction of luminary physicians and nurses worldwide. For more information, visit www.usendoscopy.com.
About STERIS Corporation
The mission of STERIS Corporation is to help our Customers create a healthier and safer world by providing innovative healthcare and life science product and service solutions around the globe. The Company is listed on the New York Stock Exchange under the symbol STE. For more information, visit www.steris.com.
US Endoscopy press releases can be found in the News section of www.usendoscopy.com . To arrange interviews concerning US Endoscopy products and services, please Contact Us.